Literature DB >> 26379151

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.

Rebecca L King1, Linda N Dao, Ellen D McPhail, Elaine S Jaffe, Jonathan Said, Steven H Swerdlow, Christopher A Sattler, Rhett P Ketterling, Jagmohan S Sidhu, Eric D Hsi, Shridevi Karikehalli, Liuyan Jiang, Sarah E Gibson, Sarah L Ondrejka, Alina Nicolae, William R Macon, Surendra Dasari, Edgardo Parrilla Castellar, Andrew L Feldman.   

Abstract

Systemic anaplastic large cell lymphomas (ALCLs) are classified into ALK-positive and ALK-negative types. We recently reported that ALK-negative ALCLs are genetically heterogenous. The largest subset, representing 30% of cases, had rearrangements of the DUSP22 locus. These cases had favorable outcomes similar to ALK-positive ALCL, and superior to other ALK-negative ALCLs. Here, we examined the morphologic features of these cases in more detail. First, we conducted blinded review of hematoxylin and eosin slides of 108 ALCLs from our previous study, scoring cases for the presence of 3 histologic patterns and 5 cell types. Cases then were unblinded and re-reviewed to understand these features further. DUSP22-rearranged ALCLs were more likely than other ALK-negative ALCLs to have so-called doughnut cells (23% vs. 5%; P=0.039), less likely to have pleomorphic cells (23% vs. 49%; P=0.042), and nearly always (95%) had areas with sheet-like growth (common pattern). To examine the reproducibility of these findings, we conducted blinded review of hematoxylin and eosin slides of 46 additional ALK-negative ALCLs using a 0 to 3 scoring system to predict likelihood of DUSP22 rearrangement, the results of which correlated strongly with subsequent findings by fluorescence in situ hybridization (P<0.0001). Although all ALCLs share certain morphologic features, ALCLs with DUSP22 rearrangements show significant differences from other ALK-negative ALCLs, typically showing sheets of hallmark cells with doughnut cells and few large pleomorphic cells. These morphologic findings and our previous outcome data suggest that ALK-positive ALCLs and DUSP22-rearranged ALCLs represent prototypical ALCLs, whereas ALCLs lacking rearrangements of both DUSP22 and ALK require further study.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26379151      PMCID: PMC4834837          DOI: 10.1097/PAS.0000000000000500

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

1.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

2.  Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases.

Authors:  B A Agnarsson; M E Kadin
Journal:  Am J Surg Pathol       Date:  1988-04       Impact factor: 6.394

3.  Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

Authors:  R D Gascoyne; P Aoun; D Wu; M Chhanabhai; B F Skinnider; T C Greiner; S W Morris; J M Connors; J M Vose; D S Viswanatha; A Coldman; D D Weisenburger
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

4.  Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.

Authors:  David A Wada; Mark E Law; Eric D Hsi; David J Dicaudo; Linglei Ma; Megan S Lim; Aieska de Souza; Nneka I Comfere; Roger H Weenig; William R Macon; Lori A Erickson; Nazan Ozsan; Stephen M Ansell; Ahmet Dogan; Andrew L Feldman
Journal:  Mod Pathol       Date:  2010-12-17       Impact factor: 7.842

Review 5.  ALK-positive lymphoma: a single disease with a broad spectrum of morphology.

Authors:  D Benharroch; Z Meguerian-Bedoyan; L Lamant; C Amin; L Brugières; M J Terrier-Lacombe; E Haralambieva; K Pulford; S Pileri; S W Morris; D Y Mason; G Delsol
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

6.  Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35).

Authors:  M A Bitter; W A Franklin; R A Larson; T W McKeithan; C M Rubin; M M Le Beau; J K Stephens; J W Vardiman
Journal:  Am J Surg Pathol       Date:  1990-04       Impact factor: 6.394

7.  ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Authors:  Kerry J Savage; Nancy Lee Harris; Julie M Vose; Fred Ullrich; Elaine S Jaffe; Joseph M Connors; Lisa Rimsza; Stefano A Pileri; Mukesh Chhanabhai; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger
Journal:  Blood       Date:  2008-04-02       Impact factor: 22.113

8.  A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma.

Authors:  M C Kinney; R D Collins; J P Greer; J A Whitlock; N Sioutos; M E Kadin
Journal:  Am J Surg Pathol       Date:  1993-09       Impact factor: 6.394

9.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

10.  Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.

Authors:  A L Feldman; M Law; E D Remstein; W R Macon; L A Erickson; K L Grogg; P J Kurtin; A Dogan
Journal:  Leukemia       Date:  2008-11-06       Impact factor: 11.528

View more
  22 in total

Review 1.  Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Akira Satou; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2019-07-31       Impact factor: 2.929

2.  DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers.

Authors:  Arantza Onaindia; Sonia González de Villambrosía; Lucía Prieto-Torres; Socorro M Rodríguez-Pinilla; Santiago Montes-Moreno; Carmen González-Vela; Miguel A Piris
Journal:  Haematologica       Date:  2018-10-25       Impact factor: 9.941

3.  Genetic subtyping of breast implant-associated anaplastic large cell lymphoma.

Authors:  Naoki Oishi; Garry S Brody; Rhett P Ketterling; David S Viswanatha; Rong He; Surendra Dasari; Ming Mai; Hailey K Benson; Christopher A Sattler; Rebecca L Boddicker; Ellen D McPhail; N Nora Bennani; Christin A Harless; Kuldeep Singh; Mark W Clemens; L Jeffrey Medeiros; Roberto N Miranda; Andrew L Feldman
Journal:  Blood       Date:  2018-06-19       Impact factor: 22.113

4.  Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.

Authors:  Rebecca A Luchtel; Surendra Dasari; Naoki Oishi; Martin Bjerregård Pedersen; Guangzhen Hu; Karen L Rech; Rhett P Ketterling; Jagmohan Sidhu; Xueju Wang; Ryohei Katoh; Ahmet Dogan; N Sertac Kip; Julie M Cunningham; Zhifu Sun; Saurabh Baheti; Julie C Porcher; Jonathan W Said; Liuyan Jiang; Stephen Jacques Hamilton-Dutoit; Michael Boe Møller; Peter Nørgaard; N Nora Bennani; Wee-Joo Chng; Gaofeng Huang; Brian K Link; Fabio Facchetti; James R Cerhan; Francesco d'Amore; Stephen M Ansell; Andrew L Feldman
Journal:  Blood       Date:  2018-08-09       Impact factor: 22.113

5.  Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma.

Authors:  Rebecca A Luchtel; Michael T Zimmermann; Guangzhen Hu; Surendra Dasari; Manli Jiang; Naoki Oishi; Hailey K Jacobs; Yu Zeng; Tanya Hundal; Karen L Rech; Rhett P Ketterling; Jeong-Heon Lee; Bruce W Eckloff; Huihuang Yan; Krutika S Gaonkar; Shulan Tian; Zhenqing Ye; Marshall E Kadin; Jagmohan Sidhu; Liuyan Jiang; Jesse Voss; Brian K Link; Sergei I Syrbu; Fabio Facchetti; N Nora Bennani; Susan L Slager; Tamas Ordog; Jean-Pierre Kocher; James R Cerhan; Stephen M Ansell; Andrew L Feldman
Journal:  Blood       Date:  2019-05-17       Impact factor: 22.113

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 7.  Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum.

Authors:  John T Sandlund; Mike G Martin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 8.  Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management.

Authors:  Nabila Bennani-Baiti; Stephen Ansell; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2015-12-11       Impact factor: 2.929

Review 9.  Peripheral T-cell lymphoma - are we making progress?

Authors:  Niloufer Khan; Neval Ozkaya; Alison Moskowitz; Ahmet Dogan; Steven Horwitz
Journal:  Best Pract Res Clin Haematol       Date:  2018-07-17       Impact factor: 3.020

Review 10.  Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.

Authors:  Francisco Vega; Catalina Amador; Amy Chadburn; Eric D Hsi; Graham Slack; L Jeffrey Medeiros; Andrew L Feldman
Journal:  Mod Pathol       Date:  2021-09-28       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.